文献速递间质性肺疾病

慢性过敏性肺炎中的小气道功能障碍

Small airway dysfunction in chronic hypersensitivity pneumonitis.
PubMed 文献 · Respirology · 2017-07-26

本研究纳入20例新诊断慢性过敏性肺炎成人患者,采用超声肺图(UPG)和脉冲振荡法(IOS)评估小气道功能,并比较标准化阿唑硫嘌呤联合泼尼松治疗4周前后的变化。结果显示患者存在小气道异常,治疗后肺容积和通气分布改善,但DLCO未改善。

要点

  • 慢性过敏性肺炎患者存在小气道功能障碍,UPG和IOS可部分揭示。
  • 仅40%患者IOS显示小气道阻力升高,但全部患者X5降低和AX升高。
  • 阿唑硫嘌呤联合泼尼松治疗4周后FVC、6MWD和通气分布改善,DLCO未改善。

核心结论

  • 慢性过敏性肺炎患者存在小气道异常,UPG和IOS可部分揭示。
  • 阿唑硫嘌呤联合泼尼松治疗4周后肺容积改善,但气体交换未改善。

研究设计与样本

  • 研究纳入20例连续新诊断的慢性过敏性肺炎成人患者(16例女性),中位年龄50岁(IQR 42-54)。
  • 所有患者完成UPG、IOS、肺量计、体描计、单次呼吸DLCO和6分钟步行试验,并在诊断时和治疗4周后测量。
  • 治疗为标准化阿唑硫嘌呤联合泼尼松方案,疗程4周。

主要发现

  • 诊断时UPG第3相斜率异常升高,提示通气分布不均。
  • IOS显示全部患者X5降低和AX升高,反映低顺应性;仅8例(40%)患者R5和R5-20升高,归因于小气道阻力。
  • FENO参数均在正常范围内。
  • 治疗后FVC、6分钟步行距离和通气分布显著改善,DLCO未改善。

临床怎么用

  • 对慢性过敏性肺炎患者可考虑使用UPG和IOS评估小气道功能。
  • 阿唑硫嘌呤联合泼尼松治疗4周可改善肺容积和运动能力,但气体交换可能无改善。

局限性

  • 样本量较小(20例),可能影响结果的普遍性。
  • 未设置对照组,治疗效应需谨慎解读。
  • 随访时间仅4周,长期效果未知。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Lung biopsies from patients with hypersensitivity pneumonitis (HP) have demonstrated small airway (SA) involvement, but there is no information concerning SA function in HP, and it is unknown whether pharmacological treatment could modify its function. SA function in patients with chronic HP using ultrasonic pneumography (UPG) and impulse oscillometry (IOS) was explored. We also compared initial results with those obtained after 4 weeks of standardized treatment with azathioprine and prednisone. METHODS: The study group consisted of adults with recent diagnoses of HP. All patients completed UPG, IOS, spirometry, body plethysmography, single-breath carbon monoxide diffusing capacity (DLCO ) and the 6-min walk test (6MWT). The fraction of exhaled nitric oxide (FENO ) was obtained to assess eosinophilic airway inflammation. Measurements were taken at diagnosis and after 4 weeks of treatment. RESULTS: A total of 20 consecutive patients (16 women) with chronic HP participated in the study. Median age was 50 years (interquartile range (IQR): 42-54). At diagnosis, the UPG phase 3 slope was abnormally high, consistent with maldistribution of ventilation. For IOS, all patients had low reactance at 5 Hz (X5) and elevated reactance area (AX) reflecting low compliance, and only eight (40%) patients had elevated R5 (resistance at 5 Hz (total)) and R5-20 (resistance at 5 Hz-resistance at 20 Hz (peripheral)) attributed to SA resistance. In contrast, FENO parameters were within normal limits. After treatment, forced vital capacity (FVC), the 6-min walk distance and the distribution of ventilation showed significant improvement, although DLCO did not. CONCLUSION: Patients with chronic HP have SA abnormalities that are partially revealed by the UPG and IOS tests. Lung volumes, but not gas exchange, improved after treatment with azathioprine and prednisone.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Guerrero Zúñiga S, Sánchez Hernández J, Mateos Toledo H, et al. Small airway dysfunction in chronic hypersensitivity pneumonitis. Respirology. 2017. PMID: 28748646. doi:10.1111/resp.13124

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。